<?xml version="1.0" encoding="UTF-8"?>
<p>Patients with rheumatic diseases, particularly those on immunosuppressive therapies, form another high-risk group. Preliminary observational research points to the risk of severe COVID-19 and death in adult rheumatic patients with preexisting comorbidity (lung involvement), although the true extent of such risk remains to be ascertained.
 <xref rid="B11" ref-type="bibr">11</xref>
 <xref rid="B12" ref-type="bibr">12</xref>
 <xref rid="B13" ref-type="bibr">13</xref>
</p>
